MENU
CNSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CNS Pharmaceuticals (CNSP) Ownership - Who owns CNS Pharmaceuticals?
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors... Show more
Profile
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
5
Web
https://www.cnspharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.61M
P/E Ratio
0.00
Total Cash
548.72K
Projected Growth
N/A
Total Debt
31.19K
Revenue
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash/Share
0.37
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CNSP
Capitalization
1.61M
P/E Ratio
0.00
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash
549K
Total Cash/Share
0.37
Total Debt
31.2K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.35M
P/B Ratio
0.26
Cash Flow
N/A
Earnings
2.46K
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
33.4K
Current Ratio
1.82
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-17.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-350.34
Shares Held By Institutions
6.21M
Shares Outstanding - Current
1.5M
Total Liabilities
4.06M
Total Volume MTD
N/A
Value
1
Gain YTD
-82.143
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
5
Web
https://www.cnspharma.com